The In Vitro Activity of Essential Oils against Helicobacter Pylori Growth and Urease Activity

Izabela Korona-Glowniak1, Anna Glowniak-Lipa1, Agnieszka Ludwiczuk2

  • 1Department of Pharmaceutical Microbiology, Medical University in Lublin, 1 Chodzki Str., 20-093 Lublin, Poland.

Insights

Essential oils like cedarwood and oregano show potent anti-H. pylori activity. Cedarwood oil also inhibits urease, suggesting its potential in therapies for H. pylori infections.

Area of Science:

  • Microbiology
  • Natural Products Chemistry
  • Pharmacology

Background:

  • Helicobacter pylori (H. pylori) is a significant human pathogen.
  • Antibiotic resistance in H. pylori necessitates alternative therapeutic strategies.
  • Essential oils (EOs) represent a potential source of novel antimicrobial agents.

Purpose of the Study:

  • To evaluate the in vitro anti-H. pylori activity of various commercial essential oils.
  • To determine the phytochemical composition and urease inhibition activity of selected EOs.
  • To identify EOs effective against both reference and clinical strains of H. pylori.

Main Methods:

  • Minimal Inhibitory Concentration (MIC) determination for 26 EOs against H. pylori ATCC 43504.
  • Gas Chromatography-Mass Spectrometry (GC-MS) for phytochemical analysis.
  • Phenol red method to assess urease inhibition (IC50).
  • Principal Component Analysis (PCA) for grouping EOs based on phytochemicals and activity.

Main Results:

  • Thyme, lemongrass, cedarwood, and lemon balm oils exhibited the highest anti-H. pylori activity (MIC = 15.6 mg/L).
  • Cedarwood oil demonstrated significant urease inhibition (IC50 = 5.3 mg/L), even at sub-MIC levels.
  • Cedarwood and oregano oils were most effective against clinical H. pylori strains.
  • PCA identified three distinct phytochemical groups correlating with anti-H. pylori efficacy.

Conclusions:

  • Several essential oils, notably cedarwood and oregano, possess significant in vitro activity against H. pylori.
  • Cedarwood oil's dual action (anti-H. pylori and urease inhibition) makes it a promising candidate for complementary therapy.
  • This study highlights the potential of specific EOs as adjuncts in H. pylori eradication strategies.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
976
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
473
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
769
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.0K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
852